These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5367312)

  • 1. Effect of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and pargyline on levorphanol-induced running activity in mice.
    Hollinger M
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):419-24. PubMed ID: 5367312
    [No Abstract]   [Full Text] [Related]  

  • 2. p-Chlorophenylalanine: a specific depletor of brain serotonin.
    Koe BK; Weissman A
    J Pharmacol Exp Ther; 1966 Dec; 154(3):499-516. PubMed ID: 5297133
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of the adrenergic system on the 24-hour locomotor activity pattern in mice.
    Saelens JK; Kovacsics GB; Allen MP
    Arch Int Pharmacodyn Ther; 1968 Jun; 173(2):411-6. PubMed ID: 5684269
    [No Abstract]   [Full Text] [Related]  

  • 4. Normal rate of 3H norepinephrine uptake by isolated iris of rabbits injected with reserpine and pargyline.
    Herr B; Costa E
    Int J Neuropharmacol; 1969 Sep; 8(5):463-9. PubMed ID: 5344489
    [No Abstract]   [Full Text] [Related]  

  • 5. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
    Bloom FE; Aghajanian GK
    J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
    [No Abstract]   [Full Text] [Related]  

  • 6. The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue.
    Roth RH; Stone EA
    Biochem Pharmacol; 1968 Aug; 17(8):1581-90. PubMed ID: 5672819
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of locomotor activity by p-chlorophenylalanine and a low dose of reserpine.
    Pirch JH
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):434-40. PubMed ID: 4253932
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of pargyline pretreatment on the enhancement of the exocytotic release of norepinephrine during nerve stimulation which is induced by a benzoquinolizine compound with reserpine-like properties.
    Langley AE; Weiner N
    J Pharmacol Exp Ther; 1980 Jun; 213(3):534-8. PubMed ID: 6907314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
    Benkert O; Gluba H; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
    [No Abstract]   [Full Text] [Related]  

  • 10. The interrelation of hypothermia and depletion of noradrenaline, dopamine and 5-hydroxytryptamine from brain by reserpine, para-chlorophenylalanine and alpha-methylmetatyrosine.
    Somerville AR; Whittle BA
    Br J Pharmacol Chemother; 1967 Sep; 31(1):120-31. PubMed ID: 6055247
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic control of opiate-induced locomotor activity in mice.
    Judson BA; Goldstein A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):56-60. PubMed ID: 207859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
    Strömbom U
    Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
    [No Abstract]   [Full Text] [Related]  

  • 13. Biosynthesis and metabolism of endogenous tyramine and its normal presence in sympathetic nerves.
    Tallman JF; Saavedra JM; Axelrod J
    J Pharmacol Exp Ther; 1976 Oct; 199(1):216-21. PubMed ID: 10424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism.
    Weissman A; Koe BK
    J Pharmacol Exp Ther; 1967 Jan; 155(1):135-44. PubMed ID: 5297377
    [No Abstract]   [Full Text] [Related]  

  • 15. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
    Buterbaugh GG; Spratt JL
    J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
    [No Abstract]   [Full Text] [Related]  

  • 16. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of intraventricular dopamine on the spontaneous locomotor activity of rats pretreated with nialamide, reserpine, or alpha-methyl-p-tyrosine.
    Malec D; Kleinrok Z
    Pol J Pharmacol Pharm; 1973; 25(4):357-66. PubMed ID: 4774244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of beta-phenylethylamine derivatives on the central nervous system. (5) Changes in the volume of spontaneous movement in mice with intracerebral administration of tyramine].
    Sakurada S; Shoji T; Kisara K
    Nihon Yakurigaku Zasshi; 1975 Nov; 71(8):769-77. PubMed ID: 1240829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of p-chlorophenylalanine on opiate-induced running, analgesia, tolerance and physical dependence in mice.
    Cheney DL; Goldstein A
    J Pharmacol Exp Ther; 1971 Apr; 177(1):309-15. PubMed ID: 4254848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.